SCHEMBL18022785

SCHEMBL18022785

O=C(NCCCN1C(=O)c2ccccc2C1=O)c1ccc(CO)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT1 P26358 1/20 0.46
▸ DNMT3L Q9UJW3 1/20 0.46
▸ DNMT3A Q9Y6K1 1/20 0.46
▸ SCN9A Q15858 1/20 0.46
▸ RAB9A P51151 1/20 0.45
▸ CYP1A2 P05177 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ CYP2C19 P33261 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP19A1 P11511 1/20 0.42
▸ HDAC8 Q9BY41 3/20 0.41
▸ HDAC3 O15379 2/20 0.41
▸ HDAC4 P56524 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18022786 0.91 DNMT1 (0.46) DNMT1DNMT3LDNMT3ARAB9ACYP1A2
SCHEMBL18022784 0.76 KDM4E (0.50) SCN9ACYP1A2KDM4EKMT2AMEN1
SCHEMBL18022787 0.76 EPHX2 (0.43) DNMT1DNMT3LDNMT3AKMT2AMEN1
SCHEMBL3455770 0.75 DNMT1 (0.62) DNMT1DNMT3LDNMT3ARAB9ACYP1A2
SCHEMBL17060904 0.73 KDM4E (0.49) SCN9ARAB9AKDM4EKMT2AMEN1
SCHEMBL21851995 0.72 KMT2A (0.58) RAB9ACYP1A2CYP3A4CYP2C9KMT2A
SCHEMBL21449812 0.70 RAB9A (0.44) DNMT1DNMT3LDNMT3ARAB9ACYP3A4
SCHEMBL21362830 0.70 HPGDS (0.45) SCN9ARAB9AKDM4EKMT2AMEN1
SCHEMBL24795948 0.69 MEN1 (0.58) KMT2AMEN1NPSR1ALDH1A1HDAC8
SCHEMBL21480866 0.69 KMT2A (0.58) CYP1A2CYP3A4KDM4ECYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10441669-B2 Multifunctional chelators, complexes, and compositions thereof, and methods of using same ILLINOIS INSTITUTE OF TECHNOLOGY (US) 2019-10-15 — — US disclosed
US-20160235870-A1 MULTIFUNCTIONAL CHELATORS, COMPLEXES, AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME ILLINOIS INSTITUTE OF TECHNOLOGY (US) 2016-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160235870-A1 MULTIFUNCTIONAL CHELATORS, COMPLEXES, AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME FECH, SLC40A1, TFRC DNMT1 2122/4885DNMT3L 3832/4885DNMT3A 2958/4885
US-10441669-B2 Multifunctional chelators, complexes, and compositions thereof, and methods of using same FECH, SLC40A1, TFRC DNMT1 2122/4885DNMT3L 3832/4885DNMT3A 2958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback